Vasopressin-receptor antagonist therapy in patients with hyponatraemia.

Tushar Vachharajani, Vidula Vachharajani

Journal: British journal of hospital medicine (London, England : 2005) 2007;68(7):367-72

PMID: 17663307

Abstract

Hyponatraemia often complicates the treatment of underlying conditions in patients who are seriously ill. Arginine vasopressin receptor antagonists block the action of arginine vasopressin and correct sodium and water imbalance in patients with euvolaemic or hypervolaemic hyponatraemia.

Address: Department of Internal Medicine/Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.